DETAILS, FICTION AND API MANUFACTURING

“The existing scenario has exposed some structural weaknesses during the EU’s medicines source chain as well as a superior dependence on non-EU countries for active pharmaceutical ingredients,” Kyriakides mentioned. She encouraged that supply chain difficulties be addressed within an EU pharmaceutical strategy anticipated to generally be rele